Caribou Biosciences, Inc. (CRBU)
NASDAQ: CRBU · Real-Time Price · USD
1.430
+0.120 (9.16%)
At close: Jan 31, 2025, 4:00 PM
1.460
+0.030 (2.10%)
After-hours: Jan 31, 2025, 7:01 PM EST
Caribou Biosciences Market Cap
Caribou Biosciences has a market cap or net worth of $129.49 million as of January 31, 2025. Its market cap has decreased by -72.06% in one year.
Market Cap
129.49M
Enterprise Value
-124.88M
1-Year Change
-72.06%
Ranking
Category
Stock Price
$1.43
Market Cap Chart
Since the IPO on July 23, 2021, Caribou Biosciences's market cap has decreased from $888.48M to $129.49M, a decrease of -85.43%. That is a compound annual growth rate of -42.09%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 30, 2025 | 118.62M | -17.61% |
| Dec 31, 2024 | 143.98M | -71.59% |
| Dec 29, 2023 | 506.71M | 32.27% |
| Dec 30, 2022 | 383.09M | -57.82% |
| Dec 31, 2021 | 908.30M | 2.23% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 730.32B |
| UnitedHealth Group | 499.25B |
| Novo Nordisk | 375.61B |
| Johnson & Johnson | 366.32B |
| AbbVie | 324.98B |
| Merck & Co. | 249.98B |
| Thermo Fisher Scientific | 228.64B |
| Abbott Laboratories | 221.89B |